WA
GRNAW

Whitebox Advisors’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Whitebox Advisors’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-32,183
Closed -$428 – 457
2023
Q2 		$428 Hold
32,183
– – ﹤0.01% 427
2023
Q1 		$1.65K Hold
32,183
– – ﹤0.01% 518
2022
Q4 		$2.74K Hold
32,183
– – ﹤0.01% 605
2022
Q3 		$7K Hold
32,183
– – ﹤0.01% 696
2022
Q2 		$7K Hold
32,183
– – ﹤0.01% 726
2022
Q1 		$25K Sell
32,183
-2,798
-8% -$2.05K ﹤0.01% 673
2021
Q4 		$42K Buy
+34,981
New +$39.9K ﹤0.01% 632
2021
Q2 		– Sell
-37,250
Closed -$32.9K – 593
2021
Q1 		$32K Buy
+37,250
New +$38.8K ﹤0.01% 344

Whitebox Advisors's GRNAW Position: Q3 2023 in Review

Whitebox Advisors sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 32,183 shares — an estimated $428 sold.

Whitebox Advisors first reported a position in GRNAW in Q1 2021 and held it in 8 quarters. The position peaked at $42K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

  • Whitebox Advisors reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
  • Whitebox Advisors sold 32,183 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $428.
  • Whitebox Advisors first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 8 quarters.
  • Whitebox Advisors's GreenLight Biosciences Holdings, PBC Warrant position peaked at $42K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Whitebox Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.